Share ownership Bayer AG

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Xetra Other stock markets 09:05:12 20/07/2026 pm IST			5-day change	1st Jan Change
47.31 ^EUR	-2.37%		-5.23%	+27.83%

17/07	Bayer Ag and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials	CI
17/07	BAYER AG : JP Morgan keeps its Buy rating	ZD

Share class: Bayer AG

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	98,24,24,082	98,24,24,082 ( 100 %)	0	100 %

Major shareholders: Bayer AG

Name	Stocks	%	Valuation
Amundi Asset Management SAS (Investment Management) 3.093 %	3,03,88,944	3.093 %	1 682 M €
Silchester International Investors LLP 2.994 %	2,94,09,766	2.994 %	1 628 M €
Harris Associates LP 2.981 %	2,92,85,913	2.981 %	1 621 M €
Temasek Holdings Pte Ltd. (Investment Management) 2.9 %	2,84,90,299	2.9 %	1 577 M €
Dodge & Cox 2.874 %	2,82,33,293	2.874 %	1 563 M €
FIL Investments International (Germany) 0.2173 %	21,34,886	0.2173 %	118 M €
Cobas Asset Management SGIIC SA 0.1903 %	18,69,392	0.1903 %	103 M €
Sjunde AP-fonden 0.1381 %	13,57,193	0.1381 %	75 M €
State Street Global Advisors Europe Ltd. 0.1027 %	10,09,265	0.1027 %	56 M €
Caixabank Asset Management SGIIC SAU 0.0852 %	8,36,594	0.0852 %	46 M €
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Stocks	%	Valuation
Kahn Brothers Group, Inc. 0.1658 %	65,13,893	0.1658 %	90 M €
Dodge & Cox 0.0398 %	15,62,425	0.0398 %	22 M €
Goldman Sachs Asset Management International 0.007713 %	3,03,100	0.007713 %	4 M €
Great Lakes Advisors LLC 0.003041 %	1,19,517	0.003041 %	2 M €
RhumbLine Advisers LP 0.001734 %	68,123	0.001734 %	942 618 €
GAMMA Investing LLC 0.001049 %	41,204	0.001049 %	570 140 €
Atlas Capital Advisors, Inc. 0.000904 %	35,510	0.000904 %	491 352 €
Ayalon Mutual Funds Ltd. 0.00084 %	33,000	0.00084 %	456 621 €
Moloney Securities Asset Management LLC 0.00077 %	30,240	0.00077 %	418 431 €
Wintrust Private Trust Co. NA 0.000511 %	20,097	0.000511 %	278 082 €
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	17.3%
Others	0.67%
Unknown	82.03%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	6.83%
United Kingdom	3.26%
France	3.17%
Singapore	2.9%
Germany	0.48%
Spain	0.34%
Switzerland	0.15%
Ireland	0.15%
Sweden	0.14%
Italy	0.09%
South Africa	0.08%
Luxembourg	0.08%
Austria	0.04%
Denmark	0.04%
Norway	0.03%
Taiwan	0.03%
Belgium	0.02%
Japan	0.02%
Canada	0.02%
Finland	0.02%
China	0.01%
Australia	0.01%
Liechtenstein	0.01%
Hong Kong	0.01%
Greece	0.01%

Based on 1000 largest holdings

Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).

Employees

87,757

Sector

Pharmaceuticals

Calendar

Earnings release - Q2 2026

More about the company